 | • レポートコード：MRC2012A0529 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗体の種類別市場規模（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体）、用途別市場規模（病院、介護施設、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Amgen、F. Hoffmann-La Roche、Eli Lilly、Johnson & Johnson Services、AbbVie、Bristol-Myers Squibb、 ・地域別グローバル市場分析 2015年-2020年 ・抗体の北米市場（アメリカ、カナダ、メキシコ） ・抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗体の南米市場（ブラジル、アルゼンチン） ・抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体 ・用途別分析：病院、介護施設、研究機関 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antibodies market has been segmented into
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates
By Application, Antibodies has been segmented into:
Hospitals
Long-term care facilities
Research institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibodies market.
The report offers in-depth assessment of the growth and other aspects of the Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antibodies Market Share Analysis
Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibodies sales, revenue and market share for each player covered in this report.
The major players covered in Antibodies are:
Novartis
Amgen
F. Hoffmann-La Roche
Eli Lilly
Johnson & Johnson Services
AbbVie
Bristol-Myers Squibb
Among other players domestic and global, Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibodies, with price, sales, revenue and global market share of Antibodies in 2018 and 2019.
Chapter 3, the Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antibodies market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal antibodies
1.2.3 Polyclonal antibodies
1.2.4 Antibody drug conjugates
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Long-term care facilities
1.3.4 Research institutes
1.4 Overview of Global Antibodies Market
1.4.1 Global Antibodies Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche SWOT Analysis
2.3.4 F. Hoffmann-La Roche Product and Services
2.3.5 F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson Services
2.5.1 Johnson & Johnson Services Details
2.5.2 Johnson & Johnson Services Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson Services SWOT Analysis
2.5.4 Johnson & Johnson Services Product and Services
2.5.5 Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb SWOT Analysis
2.7.4 Bristol-Myers Squibb Product and Services
2.7.5 Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antibodies Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antibodies Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibodies Manufacturer Market Share in 2019
3.3.2 Top 6 Antibodies Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Antibodies Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antibodies Revenue and Market Share by Regions (2015-2020)
4.2 North America Antibodies Sales and Growth Rate (2015-2020)
4.3 Europe Antibodies Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibodies Sales and Growth Rate (2015-2020)
4.5 South America Antibodies Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antibodies Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antibodies Sales, Revenue and Market Share by Country
5.1.1 North America Antibodies Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibodies Revenue and Market Share by Country (2015-2020)
5.2 United States Antibodies Sales and Growth Rate (2015-2020)
5.3 Canada Antibodies Sales and Growth Rate (2015-2020)
5.4 Mexico Antibodies Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antibodies Sales, Revenue and Market Share by Country
6.1.1 Europe Antibodies Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antibodies Revenue and Market Share by Country (2015-2020)
6.2 Germany Antibodies Sales and Growth Rate (2015-2020)
6.3 UK Antibodies Sales and Growth Rate (2015-2020)
6.4 France Antibodies Sales and Growth Rate (2015-2020)
6.5 Russia Antibodies Sales and Growth Rate (2015-2020)
6.6 Italy Antibodies Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibodies Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antibodies Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antibodies Revenue and Market Share by Regions (2015-2020)
7.2 China Antibodies Sales and Growth Rate (2015-2020)
7.3 Japan Antibodies Sales and Growth Rate (2015-2020)
7.4 Korea Antibodies Sales and Growth Rate (2015-2020)
7.5 India Antibodies Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antibodies Sales and Growth Rate (2015-2020)
7.7 Australia Antibodies Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antibodies Sales, Revenue and Market Share by Country
8.1.1 South America Antibodies Sales and Market Share by Country (2015-2020)
8.1.2 South America Antibodies Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antibodies Sales and Growth Rate (2015-2020)
8.3 Argentina Antibodies Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibodies Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antibodies Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antibodies Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antibodies Sales and Growth Rate (2015-2020)
9.3 Turkey Antibodies Sales and Growth Rate (2015-2020)
9.4 Egypt Antibodies Sales and Growth Rate (2015-2020)
9.5 South Africa Antibodies Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antibodies Sales and Market Share by Type (2015-2020)
10.2 Global Antibodies Revenue and Market Share by Type (2015-2020)
10.3 Global Antibodies Price by Type (2015-2020)
11 Global Antibodies Market Segment by Application
11.1 Global Antibodies Sales Market Share by Application (2015-2020)
11.2 Global Antibodies Revenue Market Share by Application (2015-2020)
11.3 Global Antibodies Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antibodies Sales, Revenue and Growth Rate (2021-2025)
12.2 Antibodies Market Forecast by Regions (2021-2025)
12.2.1 North America Antibodies Market Forecast (2021-2025)
12.2.2 Europe Antibodies Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antibodies Market Forecast (2021-2025)
12.2.4 South America Antibodies Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antibodies Market Forecast (2021-2025)
12.3 Antibodies Market Forecast by Type (2021-2025)
12.3.1 Global Antibodies Sales Forecast by Type (2021-2025)
12.3.2 Global Antibodies Market Share Forecast by Type (2021-2025)
12.4 Antibodies Market Forecast by Application (2021-2025)
12.4.1 Global Antibodies Sales Forecast by Application (2021-2025)
12.4.2 Global Antibodies Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Antibodies Major Business
Table 9. Novartis Antibodies Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Antibodies Product and Services
Table 12. Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Amgen Basic Information, Manufacturing Base and Competitors
Table 14. Amgen Antibodies Major Business
Table 15. Amgen Antibodies Total Revenue (USD Million) (2017-2018)
Table 16. Amgen SWOT Analysis
Table 17. Amgen Antibodies Product and Services
Table 18. Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Antibodies Major Business
Table 21. F. Hoffmann-La Roche Antibodies Total Revenue (USD Million) (2017-2018)
Table 22. F. Hoffmann-La Roche SWOT Analysis
Table 23. F. Hoffmann-La Roche Antibodies Product and Services
Table 24. F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly Antibodies Major Business
Table 27. Eli Lilly Antibodies Total Revenue (USD Million) (2017-2018)
Table 28. Eli Lilly SWOT Analysis
Table 29. Eli Lilly Antibodies Product and Services
Table 30. Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Services Antibodies Major Business
Table 33. Johnson & Johnson Services Antibodies Total Revenue (USD Million) (2017-2018)
Table 34. Johnson & Johnson Services SWOT Analysis
Table 35. Johnson & Johnson Services Antibodies Product and Services
Table 36. Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AbbVie Basic Information, Manufacturing Base and Competitors
Table 38. AbbVie Antibodies Major Business
Table 39. AbbVie Antibodies Total Revenue (USD Million) (2017-2018)
Table 40. AbbVie SWOT Analysis
Table 41. AbbVie Antibodies Product and Services
Table 42. AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Antibodies Major Business
Table 45. Bristol-Myers Squibb Antibodies Total Revenue (USD Million) (2017-2018)
Table 46. Bristol-Myers Squibb SWOT Analysis
Table 47. Bristol-Myers Squibb Antibodies Product and Services
Table 48. Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Antibodies Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Antibodies Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Antibodies Sales by Regions (2015-2020) (K Units)
Table 52. Global Antibodies Sales Market Share by Regions (2015-2020)
Table 53. Global Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Antibodies Sales by Countries (2015-2020) (K Units)
Table 55. North America Antibodies Sales Market Share by Countries (2015-2020)
Table 56. North America Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Antibodies Revenue Market Share by Countries (2015-2020)
Table 58. Europe Antibodies Sales by Countries (2015-2020) (K Units)
Table 59. Europe Antibodies Sales Market Share by Countries (2015-2020)
Table 60. Europe Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Antibodies Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Antibodies Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Antibodies Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Antibodies Sales by Countries (2015-2020) (K Units)
Table 65. South America Antibodies Sales Market Share by Countries (2015-2020)
Table 66. South America Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Antibodies Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Antibodies Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Antibodies Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Antibodies Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Antibodies Revenue Market Share by Countries (2015-2020)
Table 72. Global Antibodies Sales by Type (2015-2020) (K Units)
Table 73. Global Antibodies Sales Share by Type (2015-2020)
Table 74. Global Antibodies Revenue by Type (2015-2020) (USD Million)
Table 75. Global Antibodies Revenue Share by Type (2015-2020)
Table 76. Global Antibodies Sales by Application (2015-2020) (K Units)
Table 77. Global Antibodies Sales Share by Application (2015-2020)
Table 78. Global Antibodies Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Antibodies Market Share Forecast by Regions (2021-2025)
Table 80. Global Antibodies Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Antibodies Market Share Forecast by Type (2021-2025)
Table 82. Global Antibodies Sales Forecast by Application (2021-2025)
Table 83. Global Antibodies Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antibodies Picture
Figure 2. Global Sales Market Share of Antibodies by Type in 2019
Figure 3. Monoclonal antibodies Picture
Figure 4. Polyclonal antibodies Picture
Figure 5. Antibody drug conjugates Picture
Figure 6. Antibodies Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Long-term care facilities Picture
Figure 9. Research institutes Picture
Figure 10. Global Antibodies Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Antibodies Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Antibodies Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Antibodies Sales Market Share by Manufacturer in 2019
Figure 31. Global Antibodies Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Antibodies Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Antibodies Revenue Market Share by Regions (2015-2020)
Figure 38. Global Antibodies Revenue Market Share by Regions in 2018
Figure 39. North America Antibodies Sales and Growth Rate (2015-2020)
Figure 40. Europe Antibodies Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antibodies Sales and Growth Rate (2015-2020)
Figure 42. South America Antibodies Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Antibodies Sales and Growth Rate (2015-2020)
Figure 44. North America Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Antibodies Sales Market Share by Countries (2015-2020)
Figure 46. North America Antibodies Sales Market Share by Countries in 2018
Figure 47. North America Antibodies Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Antibodies Revenue Market Share by Countries in 2018
Figure 49. United States Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Antibodies Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Antibodies Revenue Market Share by Countries in 2019
Figure 55. Germany Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Antibodies Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Antibodies Revenue Market Share by Regions 2019
Figure 63. China Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Antibodies Sales Market Share by Countries in 2019
Figure 70. South America Antibodies Revenue Market Share by Countries in 2019
Figure 71. Brazil Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Antibodies Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Antibodies Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Antibodies Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Antibodies Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Antibodies Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Antibodies Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Antibodies Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Antibodies Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Antibodies Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Antibodies Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Antibodies Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Antibodies Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- 抗体の世界市場（～2026年） Market Analysis and Insights: Global Antibodies Market The global Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Antibodies Scope and Market Size Antibodies market is segmented by Type, and by Application. …
- 診断用特殊抗体の世界市場（～2026年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 20750 million by 2026, from US$ 20090 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Diagnostic Specialty Antibodies Scope and Ma…
- 癌治療用モノクローナル抗体の世界市場（～2026年） The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- HER2抗体の世界市場（～2026年） The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. Market Analysis and Insights: Global HER2 Antibodies Market The global HER2 Antibodies market size is projected to reach US$ 8543.4 million by 2026, from…